RADIOGENIX SYSTEM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Radiogenix System, and what generic alternatives are available?
Radiogenix System is a drug marketed by Northstar Medical and is included in one NDA.
The generic ingredient in RADIOGENIX SYSTEM is technetium tc-99m sodium pertechnetate generator. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m sodium pertechnetate generator profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for RADIOGENIX SYSTEM?
- What are the global sales for RADIOGENIX SYSTEM?
- What is Average Wholesale Price for RADIOGENIX SYSTEM?
Summary for RADIOGENIX SYSTEM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| What excipients (inactive ingredients) are in RADIOGENIX SYSTEM? | RADIOGENIX SYSTEM excipients list |
| DailyMed Link: | RADIOGENIX SYSTEM at DailyMed |
US Patents and Regulatory Information for RADIOGENIX SYSTEM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Northstar Medical | RADIOGENIX SYSTEM | technetium tc-99m sodium pertechnetate generator | SOLUTION;INTRAVENOUS, INTRAVESICULAR, OPHTHALMIC | 202158-001 | Feb 8, 2018 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
